Skip to content

ADMA Biologics ADMA Property, plant and equipment at cost

Property, plant and equipment at cost at other companies

AbbVie logo
AbbVieABBV
Abbott logo
AbbottABT
Charles River Laboratories logo
Charles River LaboratoriesCRL
Haemonetics logo
HaemoneticsHAE
Gilead Sciences logo
Gilead SciencesGILD
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's property, plant and equipment at cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's property, plant and equipment at cost?
ADMA Biologics (ADMA) reported property, plant and equipment at cost of $105.01M in Q1 2026.
How has ADMA Biologics's property, plant and equipment at cost changed year-over-year?
ADMA Biologics's property, plant and equipment at cost increased by 12.7% year-over-year, from $93.21M to $105.01M.
What is the long-term trend for ADMA Biologics's property, plant and equipment at cost?
Over 5 years (2020 to 2025), ADMA Biologics's property, plant and equipment at cost has grown at a 15.4% compound annual growth rate (CAGR), from $50.46M to $103.41M.